HPV16 E6 TCR T Cells for Cervical Carcinoma

Clinical trial NCT05357027 · TERMINATED

Trial details

NCT number: NCT05357027
Sponsor: TCRCure Biopharma Ltd.
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Cervical Carcinoma

Start date: 2022-08-10
Primary completion: 2026-01-15
Enrollment: 5

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.